ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Elvanse 20 mg, Kapseln - 30
63023004 PPTakeda Pharma AG
Elvanse 20 mg, Kapseln27.03.2014
  16.11.2016
Lisdexamfetamine (N06BA12) 
WHO-DDD 
01.10.20.30
01.10.20. 
A+  
Yes 
IPCI
80.84Yes
    
10 %109.30
7680630230041Synthetika
6941287● 
Composition
lisdexamfetamini dimesilas 20 mg corresp. dexamfetaminum 5.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 172 (flavum), E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.2721 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Lisdexamfetamini Dimesilas20 mg correspond Dexamfetaminum 5.9 mg
BAG: Active AgentDose
Lisdexamfetamini Dimesilas20 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Propylenglycol  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home